We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Decellurization Technique Enhances Study of ECM Structure

By LabMedica International staff writers
Posted on 12 Jul 2017
Print article
Image: The in situ decellularization of tissues (ISDoT) process reveals the ECM structure of a decellularized breast cancer lymphatic metastasis (Photo courtesy of Alejandro Mayorca-Guiliani).
Image: The in situ decellularization of tissues (ISDoT) process reveals the ECM structure of a decellularized breast cancer lymphatic metastasis (Photo courtesy of Alejandro Mayorca-Guiliani).
A new method has been developed that allows complete removal of cells from within organs of the body to enhance the study of extracellular membrane (ECM) composition and structure.

ECM is a master regulator of cellular phenotype and behavior. It has a crucial role in both normal tissue homeostasis and disease pathology. Differing mechanical properties in ECM exert effects on both cell behavior and gene expression. ECM can exist in varying degrees of stiffness and elasticity, from soft brain tissues to hard bone tissues. The elasticity of the ECM can differ by several orders of magnitude. This property is primarily dependent on collagen and elastin concentration, and it has recently been shown to play an influential role in regulating numerous cell functions.

Investigators at the University of Copenhagen (Denmark) reported in the June 12, 2017, online edition of the journal Nature Medicine that they had developed a fast and efficient approach to enhance the study of ECM composition and structure. Termed in situ decellularization of tissues (ISDoT), it allows whole organs to be decellularized, leaving native ECM architecture intact. These three-dimensional decellularized tissues can be studied using high-resolution fluorescence and second harmonic imaging, and can be used for quantitative proteomic interrogation of the ECM.

The investigators performed high-resolution sub-micron imaging of matrix topography in normal tissue and over the course of primary tumor development and progression to metastasis in mice. Results of these studies provided the first detailed imaging of the metastatic niche. Furthermore, these data showed that cancer-driven ECM remodeling was organ specific, and that it was accompanied by comprehensive changes in ECM composition and topological structure. The investigators also described differing patterns of basement-membrane organization surrounding different types of blood vessels in healthy and diseased tissues.

The investigators stated that their method was superior to other methods tested in its ability to preserve the structural integrity of the ECM, facilitate high-resolution imaging, and quantitatively detect ECM proteins.

"We have developed a technique to obtain intact organ scaffolds and to image them using microscopes. We are the first to image the structures of primary and metastatic tumors as well as healthy organs in this way," said senior author Dr. Janine Erler, professor in the biotech research and innovation center at the University of Copenhagen. "We are now re-introducing cells into our extracellular matrix scaffolds, bringing them back to life, to study how tumors form and how cancer progresses. This is extremely exciting and offers a unique opportunity to study how cells behave in their native environment."

Related Links:
University of Copenhagen

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.